Aldosterone increases plasminogen activator inhibitor-1 synthesis in rat cardiomyocytes
- PMID: 15921847
- DOI: 10.1016/j.mce.2005.03.016
Aldosterone increases plasminogen activator inhibitor-1 synthesis in rat cardiomyocytes
Abstract
Plasminogen activator inhibitor-1 (PAI-1) is an anti-thrombolytic factor that also promotes tissue fibrosis. Under certain conditions, exposure to aldosterone can result in cardiac fibrosis by an unknown mechanism. In the current study, we tested the hypothesis that PAI-1 is a mediator of aldosterone's fibrotic effects. Aldosterone increased levels of PAI-1 mRNA and protein in the H9c2 rat cardiac cell line, responses that could be blocked by the mineralocorticoid receptor (MR) antagonist spironolactone. Confocal microscopy confirmed an effect of aldosterone to increase PAI-1 expression with reversal by spironolactone. Aldosterone also increased PAI-1 expression in neonatal rat cardiomyocytes, which was again blocked by spironolactone. In the neonatal cardiomyocytes (but not the H9c2 cells), anti-transforming growth factor-beta1 antibody inhibited the PAI-1 response to aldosterone. In summary, aldosterone directly increased PAI-1 expression in two different cardiac muscle cell types, an effect that was dependent on MR. In the neonatal cells, there appeared to be a requirement for transforming growth factor-beta1.
Similar articles
-
[Effect of aldosterone on the expression of plasminogen activator inhibitor-1 in renal mesangial cells: experiment with rat renal mesangial cells].Zhonghua Yi Xue Za Zhi. 2007 Sep 11;87(34):2439-42. Zhonghua Yi Xue Za Zhi. 2007. PMID: 18036328 Chinese.
-
Growth state-dependent regulation of plasminogen activator inhibitor type-1 gene expression during epithelial cell stimulation by serum and transforming growth factor-beta1.J Cell Physiol. 1999 Oct;181(1):96-106. doi: 10.1002/(SICI)1097-4652(199910)181:1<96::AID-JCP10>3.0.CO;2-I. J Cell Physiol. 1999. PMID: 10457357
-
Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II/NG-nitro-L-arginine methyl ester-induced myocardial injury.Circulation. 2003 Nov 18;108(20):2517-23. doi: 10.1161/01.CIR.0000097000.51723.6F. Epub 2003 Oct 27. Circulation. 2003. PMID: 14581407
-
Nongenomic effects of mineralocorticoid receptor activation in the cardiovascular system.Steroids. 2005 May-Jun;70(5-7):347-51. doi: 10.1016/j.steroids.2005.02.004. Epub 2005 Mar 24. Steroids. 2005. PMID: 15862816 Review.
-
Rapid effects of aldosterone on vascular cells: clinical implications.Steroids. 2004 Aug;69(8-9):575-8. doi: 10.1016/j.steroids.2004.05.005. Steroids. 2004. PMID: 15288772 Review.
Cited by
-
Role of Shear Stress and tPA Concentration in the Fibrinolytic Potential of Thrombi.Int J Mol Sci. 2021 Feb 20;22(4):2115. doi: 10.3390/ijms22042115. Int J Mol Sci. 2021. PMID: 33672724 Free PMC article.
-
This is not Dr. Conn's aldosterone anymore.Trans Am Clin Climatol Assoc. 2011;122:229-43. Trans Am Clin Climatol Assoc. 2011. PMID: 21686229 Free PMC article. Review.
-
Novel Insights into the Crosstalk between Mineralocorticoid Receptor and G Protein-Coupled Receptors in Heart Adverse Remodeling and Disease.Int J Mol Sci. 2018 Nov 27;19(12):3764. doi: 10.3390/ijms19123764. Int J Mol Sci. 2018. PMID: 30486399 Free PMC article. Review.
-
Aldosterone induces circadian gene expression of clock genes in H9c2 cardiomyoblasts.Heart Vessels. 2007 Jul;22(4):254-60. doi: 10.1007/s00380-006-0968-3. Epub 2007 Jul 20. Heart Vessels. 2007. PMID: 17653520
-
Aldosterone, but not angiotensin II, increases profibrotic factors in kidney of adrenalectomized stroke-prone spontaneously hypertensive rats.Am J Physiol Endocrinol Metab. 2008 Aug;295(2):E305-12. doi: 10.1152/ajpendo.00512.2007. Epub 2008 May 20. Am J Physiol Endocrinol Metab. 2008. PMID: 18492773 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
